Pegylated Interferon Treatment for the Effective Clearance of Hepatitis B Surface Antigen in Inactive HBsAg Carriers: A Meta-Analysis

BACKGROUND: Expanding antiviral therapy to benefit more populations and optimizing treatment to improve prognoses are two main objectives in current guidelines on antiviral therapy. However, the guidelines do not recommend antiviral therapy for inactive hepatitis B surface antigen (HBsAg) carriers (...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Aixin, Lin, Xiao, Lu, Junfeng, Ren, Shan, Cao, Zhenhuan, Zheng, Sujun, Hu, Zhongjie, Li, Hong, Shen, Chengli, Chen, Xinyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600041/
https://www.ncbi.nlm.nih.gov/pubmed/34804072
http://dx.doi.org/10.3389/fimmu.2021.779347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600041/
https://www.ncbi.nlm.nih.gov/pubmed/34804072
http://dx.doi.org/10.3389/fimmu.2021.779347

Ejemplares similares